Is gonococcal disease preventable? The importance of understanding immunity and pathogenesis in vaccine development.
about
Antimicrobial resistance in Neisseria gonorrhoeae: Global surveillance and a call for international collaborative actionCandidatus Mycoplasma girerdii replicates, diversifies, and co-occurs with Trichomonas vaginalis in the oral cavity of a premature infant.The MisR Response Regulator Is Necessary for Intrinsic Cationic Antimicrobial Peptide and Aminoglycoside Resistance in Neisseria gonorrhoeae.MetQ of Neisseria gonorrhoeae Is a Surface-Expressed Antigen That Elicits Bactericidal and Functional Blocking Antibodies.Future prospects for new vaccines against sexually transmitted infections.Routine testing of Mycoplasma genitalium and Trichomonas vaginalis.The next chapter for group B meningococcal vaccines.Infection: Proof of principle for effectiveness of a gonorrhoea vaccine.The sweet side of the pathogenic Neisseria: the role of glycan interactions in colonisation and disease.Experimental vaccine induces Th1-driven immune responses and resistance to Neisseria gonorrhoeae infection in a murine model.Refinement of immunizing antigens to produce functional blocking antibodies against the AniA nitrite reductase of Neisseria gonorrhoeae.Intractable problems require novel solutions: it's time to get serious about developing a gonorrhoea vaccine.Phase variation of DNA methyltransferases and the regulation of virulence and immune evasion in the pathogenic Neisseria.Potential targets for next generation anti-microbial glycoconjugate vaccines.Novel Whole-Cell Inactivated Microparticles as Vaccine Formulation in Microneedle-Based Transdermal Immunization
P2860
Q32383726-BC012021-E541-41E9-8F03-54547C607D55Q33812805-5342ACC4-01A7-4305-95B8-B56064D170C4Q37120015-84D1E74C-926B-42DA-87FB-2489B85DB716Q37611972-F1A4FF68-4D38-4468-9E8E-B2F19C45470BQ37665012-F68D9D88-DFD0-402E-87D4-4CFDEBA211BBQ37834699-E6B9DC01-5A62-4D40-A65C-1654457A67E8Q38677309-41FCB47F-040B-47F0-A3EC-44F50721F817Q40072827-8B7E0CF7-96D4-481A-B9CC-4C81E5CC4E91Q40165094-242C0CB4-E2A5-46C6-A317-4115F5FB5FF3Q40303647-DFF7817C-17F3-40C1-AB8D-A29FA085F578Q41237712-E09E1489-74A8-4FEC-BEEA-C0CDF06DCAC2Q42328587-F5054CFD-F9EB-4383-9BDA-1ADED20071F9Q47875777-7C64A14F-3CAF-4B69-9F66-656E7AC3AE9AQ53701548-9FCF5838-942A-4F4D-8B82-DC05430C1A77Q58764305-F265D256-8FE2-4A8A-B8CA-DF0ACC53817F
P2860
Is gonococcal disease preventable? The importance of understanding immunity and pathogenesis in vaccine development.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 January 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Is gonococcal disease preventa ...... enesis in vaccine development.
@en
Is gonococcal disease preventa ...... enesis in vaccine development.
@nl
type
label
Is gonococcal disease preventa ...... enesis in vaccine development.
@en
Is gonococcal disease preventa ...... enesis in vaccine development.
@nl
prefLabel
Is gonococcal disease preventa ...... enesis in vaccine development.
@en
Is gonococcal disease preventa ...... enesis in vaccine development.
@nl
P2093
P2860
P921
P1476
Is gonococcal disease preventa ...... enesis in vaccine development.
@en
P2093
Jennifer L Edwards
Kate L Seib
Michael P Jennings
P2860
P304
P356
10.3109/1040841X.2015.1105782
P407
P5008
P577
2016-01-23T00:00:00Z
2016-11-01T00:00:00Z